The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 05, 2020
Filed:
Jul. 07, 2017
Applicant:
Glaxosmithkline Intellectual Property Development Limited, Brentford, GB;
Inventors:
Andreas Crameri, Stevenage, GB;
Malcolm Leithhead Hill, Stevenage, GB;
David Graham Tew, Stevenage, GB;
Assignee:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED, Brentford, Middlesex, GB;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6811 (2018.01); C12Q 1/6855 (2018.01); C12Q 1/686 (2018.01); C07H 21/00 (2006.01); C12N 9/00 (2006.01); C07H 1/00 (2006.01); G01N 30/02 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6811 (2013.01); C07H 1/00 (2013.01); C07H 21/00 (2013.01); C12N 9/93 (2013.01); C12Q 1/686 (2013.01); C12Q 1/6855 (2013.01); C12Y 605/01001 (2013.01); C07K 2319/20 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01); G01N 2030/027 (2013.01);
Abstract
Disclosed herein are novel processes for the production of oligonucleotides that are suitable for use in the production of chemically modified oligonucleotides, such as those for use in therapy.